{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:17:48Z","timestamp":1781878668123,"version":"3.54.5"},"reference-count":119,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007112","name":"University of Cape Town","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100007112","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Research Foundation of South Africa","award":["UID:111707"],"award-info":[{"award-number":["UID:111707"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>In the face of the recent pandemic and emergence of infectious diseases of viral origin, research on parasitic diseases such as malaria continues to remain critical and innovative methods are required to target the rising widespread resistance that renders conventional therapies unusable. The prolific use of auxiliary metallo-fragments has augmented the search for novel drug regimens in an attempt to combat rising resistance. The development of organometallic compounds (those containing metal-carbon bonds) as antimalarial drugs has been exemplified by the clinical development of ferroquine in the nascent field of Bioorganometallic Chemistry. With their inherent physicochemical properties, organometallic complexes can modulate the discipline of chemical biology by proffering different modes of action and targeting various enzymes. With the beneficiation of platinum group metals (PGMs) in mind, this review aims to describe recent studies on the antimalarial activity of PGM-based organometallic complexes. This review does not provide an exhaustive coverage of the literature but focusses on recent advances of bioorganometallic antimalarial drug leads, including a brief mention of recent trends comprising interactions with biomolecules such as heme and intracellular catalysis. This resource can be used in parallel with complementary reviews on metal-based complexes tested against malaria.<\/jats:p>","DOI":"10.3390\/molecules25225276","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T20:17:52Z","timestamp":1605212272000},"page":"5276","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Recent Advances in the Biological Investigation of Organometallic Platinum-Group Metal (Ir, Ru, Rh, Os, Pd, Pt) Complexes as Antimalarial Agents"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1608-6801","authenticated-orcid":false,"given":"Mziyanda","family":"Mbaba","sequence":"first","affiliation":[{"name":"Department of Chemistry, Faculty of Science, University of Cape Town, Rondebosch, Cape Town 7700, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9823-6342","authenticated-orcid":false,"given":"Taryn M.","family":"Golding","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Science, University of Cape Town, Rondebosch, Cape Town 7700, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2892-5481","authenticated-orcid":false,"given":"Gregory S.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Science, University of Cape Town, Rondebosch, Cape Town 7700, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"ref_1","unstructured":"(2020, October 15). Global Polio Eradication Initiative Applauds WHO African Region for Wild Polio-Free Certification. Available online: https:\/\/www.who.int\/news\/item\/25-08-2020-global-polio-eradication-initiative-applauds-who-african-region-for-wild-polio-free-certification."},{"key":"ref_2","unstructured":"(2020, October 15). Malaria. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/malaria."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/01.qco.0000186848.46417.6c","article-title":"Artemisinin-based combinations","volume":"18","author":"Ashley","year":"2005","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_4","unstructured":"World Health Organization (2019). World Malaria Report 2018, World Health Organization."},{"key":"ref_5","unstructured":"World Health Organization (2014). Status Report on Artemisinin Resistance, World Health Organization."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cbpa.2012.01.013","article-title":"The potential of organometallic complexes in medicinal chemistry","volume":"16","author":"Gasser","year":"2012","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"102925","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: The first metal based anticancer drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4155\/fmc-2017-0317","article-title":"Anticancer metallodrugs: Where is the next cisplatin?","volume":"10","author":"Hanif","year":"2018","journal-title":"Future Med. Chem."},{"key":"ref_9","unstructured":"Hartley, F.R. (1991). Chemistry of the Platinum Group Metals: Recent Developments, Elsevier Science Publishers B.V."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ccr.2015.06.014","article-title":"The development of RAPTA compounds for the treatment of tumors","volume":"306","author":"Murray","year":"2016","journal-title":"Coord. Chem. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1021\/acs.jmedchem.7b01689","article-title":"Ru (II) compounds: Next-generation anticancer metallotherapeutics?","volume":"61","author":"Thota","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jorganchem.2018.04.021","article-title":"Half-sandwich complexes of platinum group metals (Ir, Rh, Ru and Os) and some recent biological and catalytic applications","volume":"866","author":"Gichumbi","year":"2018","journal-title":"J. Organomet. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ccr.2017.11.014","article-title":"Platinum coordination compounds with potent anticancer activity","volume":"375","author":"Deo","year":"2018","journal-title":"Coord. Chem. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5459461","DOI":"10.1155\/2019\/5459461","article-title":"Developments in Platinum-Group Metals as Dual Antibacterial and Anticancer Agents","volume":"2019","author":"Odularu","year":"2019","journal-title":"J. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1016\/j.ejmech.2011.09.031","article-title":"Novel platinum (II) and palladium (II) complexes of thiosemicarbazones derived from 5-substitutedthiophene-2-carboxaldehydes and their antiviral and cytotoxic activities","volume":"46","author":"Balzarini","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ccr.2018.08.009","article-title":"Photoactivated platinum-based anticancer drugs","volume":"376","author":"Imran","year":"2018","journal-title":"Coord. Chem. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cbpa.2019.10.004","article-title":"Metal-based photosensitizers for photodynamic therapy: The future of multimodal oncology?","volume":"56","author":"McFarland","year":"2020","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1389557043487493","article-title":"Metal complexes as chemotherapeutic agents against tropical diseases: Trypanosomiasis, malaria and leishmaniasis","volume":"4","author":"Anzellotti","year":"2004","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.1039\/c2dt12247b","article-title":"The therapeutic potential of metal-based antimalarial agents: Implications for the mechanism of action","volume":"41","author":"Biot","year":"2012","journal-title":"Dalton Trans."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1039\/C7MT00196G","article-title":"Platinum (ii)\u2013chloroquine complexes are antimalarial agents against blood and liver stages by impairing mitochondrial function","volume":"9","author":"Macedo","year":"2017","journal-title":"Metallomics"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1016\/j.poly.2006.12.010","article-title":"Synthesis, characterization and antimalarial activity of new iridium\u2013chloroquine complexes","volume":"26","author":"Navarro","year":"2007","journal-title":"Polyhedron"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1039\/C3DT52090K","article-title":"Synthesis and evaluation of new polynuclear organometallic Ru (II), Rh (III) and Ir (III) pyridyl ester complexes as in vitro antiparasitic and antitumor agents","volume":"43","author":"Chellan","year":"2014","journal-title":"Dalton Trans."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jorganchem.2013.11.025","article-title":"Heterometallic half-sandwich complexes containing a ferrocenyl motif: Synthesis, molecular structure, electrochemistry and antiplasmodial evaluation","volume":"752","author":"Nkoana","year":"2014","journal-title":"J. Organomet. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1039\/C5DT03739E","article-title":"Pentamethylcyclopentadienyl-rhodium and iridium complexes containing (N^ N and N^ O) bound chloroquine analogue ligands: Synthesis, characterization and antimalarial properties","volume":"45","author":"Ekengard","year":"2016","journal-title":"Dalton Trans."},{"key":"ref_25","first-page":"158","article-title":"A pyrazine amide-4-aminoquinoline hybrid and its rhodium and iridium pentamethylcyclopentadienyl complexes; evaluation of anti-mycobacterial and anti-plasmodial activities","volume":"61","author":"Ekengard","year":"2017","journal-title":"J. Mex. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jinorgbio.2018.11.018","article-title":"Evaluation of PTA-derived ruthenium (II) and iridium (III) quinoline complexes against chloroquine-sensitive and resistant strains of the Plasmodium falciparum malaria parasite","volume":"191","author":"Stringer","year":"2019","journal-title":"J. Inorg. Biochem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/1389557517666170510113453","article-title":"Design of Ru-arene complexes for antitumor drugs","volume":"18","author":"Su","year":"2018","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/j.1365-2958.2010.07272.x","article-title":"Efflux of a range of antimalarial drugs and \u2018chloroquine resistance reversers\u2019 from the digestive vacuole in malaria parasites with mutant PfCRT","volume":"77","author":"Lehane","year":"2010","journal-title":"Mol. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"11543","DOI":"10.1039\/D0DT01935F","article-title":"Quinoline-triazole half-sandwich iridium (III) complexes: Synthesis, antiplasmodial activity and preliminary transfer hydrogenation studies","volume":"49","author":"Melis","year":"2020","journal-title":"Dalton Trans."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"10078","DOI":"10.1002\/chem.201801090","article-title":"Organometallic conjugates of the drug sulfadoxine for combatting antimicrobial resistance","volume":"24","author":"Chellan","year":"2018","journal-title":"Chem. Eur. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmech.2018.10.019","article-title":"Structure-activity relationship studies of antiplasmodial cyclometallated ruthenium (II), rhodium (III) and iridium (III) complexes of 2-phenylbenzimidazoles","volume":"161","author":"Rylands","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"112694","DOI":"10.1016\/j.ejmech.2020.112694","article-title":"Antimicrobial evaluation of neutral and cationic iridium (III) and rhodium (III) aminoquinoline-benzimidazole hybrid complexes","volume":"206","author":"Baartzes","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1002\/anie.200600680","article-title":"Olefin-metathesis catalysts for the preparation of molecules and materials (Nobel lecture)","volume":"45","author":"Grubbs","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.enconman.2011.01.012","article-title":"Ruthenium based redox flow battery for solar energy storage","volume":"52","author":"Chakrabarti","year":"2011","journal-title":"Energy Convers. Manag."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1039\/c2cs15299a","article-title":"Ruthenium (II) polypyridyl complexes and DNA\u2014From structural probes to cellular imaging and therapeutics","volume":"41","author":"Gill","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1039\/b904071d","article-title":"Recent developments in ruthenium anticancer drugs","volume":"1","author":"Levina","year":"2009","journal-title":"Metallomics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"9904","DOI":"10.1039\/C9CC04098F","article-title":"Functionalization and cancer-targeting design of ruthenium complexes for precise cancer therapy","volume":"55","author":"Liu","year":"2019","journal-title":"Chem. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1021\/jm950729w","article-title":"Toward a novel metal-based chemotherapy against tropical diseases. 2. Synthesis and antimalarial activity in vitro and in vivo of new ruthenium\u2212 and rhodium\u2212 chloroquine complexes","volume":"39","author":"Navarro","year":"1996","journal-title":"J. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Beagley, P., Blackie, M.A., Chibale, K., Clarkson, C., Moss, J.R., and Smith, P.J. (2002). Synthesis and antimalarial activity in vitro of new ruthenocene\u2013chloroquine analogues. J. Chem. Soc. Dalton Trans., 4426\u20134433.","DOI":"10.1039\/B205432A"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00775-009-0498-4","article-title":"The antimalarial activity of Ru\u2013chloroquine complexes against resistant Plasmodium falciparum is related to lipophilicity, basicity, and heme aggregation inhibition ability near water\/n-octanol interfaces","volume":"14","author":"Rajapakse","year":"2009","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1021\/ic802220w","article-title":"Synthesis, characterization, and in vitro antimalarial and antitumor activity of new ruthenium (II) complexes of chloroquine","volume":"48","author":"Rajapakse","year":"2009","journal-title":"Inorg. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1039\/c2dt12083f","article-title":"Ruthenium (II) arene complexes with chelating chloroquine analogue ligands: Synthesis, characterization and in vitro antimalarial activity","volume":"41","author":"Glans","year":"2012","journal-title":"Dalton Trans."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1039\/c2mt20063e","article-title":"Opening up the advantages of the ruthenocenic bioprobes of ferroquine: Distribution and localization in Plasmodium falciparum-infected erythrocytes","volume":"4","author":"Biot","year":"2012","journal-title":"Metallomics"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1590\/0074-02760150163","article-title":"Antiplasmodial activity of iron (II) and ruthenium (II) organometallic complexes against Plasmodium falciparum blood parasites","volume":"110","author":"Souza","year":"2015","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"19314","DOI":"10.1039\/C5DT02410B","article-title":"Antimalarial activity of ruthenium (II) and osmium (II) arene complexes with mono-and bidentate chloroquine analogue ligands","volume":"44","author":"Ekengard","year":"2015","journal-title":"Dalton Trans."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1039\/C4DT03234A","article-title":"Improved antiparasitic activity by incorporation of organosilane entities into half-sandwich ruthenium (II) and rhodium (III) thiosemicarbazone complexes","volume":"44","author":"Adams","year":"2015","journal-title":"Dalton Trans."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1039\/c3dt32740j","article-title":"The synthesis and antiparasitic activity of aryl-and ferrocenyl-derived thiosemicarbazone ruthenium (II)\u2013arene complexes","volume":"42","author":"Adams","year":"2013","journal-title":"Dalton Trans."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1021\/om300945c","article-title":"Synthesis, characterization, and pharmacological evaluation of silicon-containing aminoquinoline organometallic complexes as antiplasmodial, antitumor, and antimycobacterial agents","volume":"32","author":"Li","year":"2013","journal-title":"Organometallics"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1021\/om500622p","article-title":"Synthesis and evaluation of a carbosilane congener of ferroquine and its corresponding half-sandwich ruthenium and rhodium complexes for antiplasmodial and \u03b2-hematin inhibition activity","volume":"33","author":"Li","year":"2014","journal-title":"Organometallics"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1517\/13543784.13.9.1149","article-title":"Exploitation of silicon medicinal chemistry in drug discovery","volume":"13","author":"Mills","year":"2004","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2174\/1567269054867031","article-title":"The place of the bioisosteric sila-substitution in drug design","volume":"2","author":"Englebienne","year":"2005","journal-title":"Drug Des. Rev. Online"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1021\/om040067l","article-title":"Sila-haloperidol: A silicon analogue of the dopamine (D2) receptor antagonist haloperidol","volume":"23","author":"Tacke","year":"2004","journal-title":"Organometallics"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1021\/om040084a","article-title":"Syntheses and pharmacological properties of the histaminic H1 antagonists sila-terfenadine-A, sila-terfenadine-B, disila-terfenadine, and sila-fexofenadine: A study on C\/Si bioisosterism","volume":"23","author":"Tacke","year":"2004","journal-title":"Organometallics"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00044-016-1769-6","article-title":"Synthesis of an organo-ruthenium aminoquinoline-trioxane hybrid and evaluation of its activity against Plasmodium falciparum and its toxicity toward normal mammalian cells","volume":"26","author":"Deregnaucourt","year":"2017","journal-title":"Med. Chem. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1039\/C6MD00251J","article-title":"Biological assessment of substituted quinoline based heteroleptic organometallic compounds","volume":"7","author":"Mehta","year":"2016","journal-title":"MedChemComm"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1080\/07391102.2016.1189360","article-title":"Biological applications of pyrazoline-based half-sandwich ruthenium (III) coordination compounds","volume":"35","author":"Mehta","year":"2017","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drup.2006.05.002","article-title":"DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity","volume":"9","author":"Brabec","year":"2006","journal-title":"Drug Resist. Updat."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1039\/B817016A","article-title":"From cisplatin to photoreactive Ru complexes: Targeting DNA for biomedical applications","volume":"33","author":"Moucheron","year":"2009","journal-title":"New J. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1039\/C5DT04338G","article-title":"Rhodium complexes as therapeutic agents","volume":"45","author":"Ma","year":"2016","journal-title":"Dalton Trans."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jorganchem.2015.04.009","article-title":"Synthesis, characterization and pharmacological evaluation of ferrocenyl azines and their rhodium (I) complexes","volume":"788","author":"Stringer","year":"2015","journal-title":"J. Organomet. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ica.2016.02.058","article-title":"Synthesis, characterization, antiplasmodial evaluation and electrochemical studies of water-soluble heterobimetallic ferrocenyl complexes","volume":"446","author":"Baartzes","year":"2016","journal-title":"Inorg. Chim. Acta"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.1002\/ange.201303690","article-title":"The ferroquine antimalarial conundrum: Redox activation and reinvasion inhibition","volume":"125","author":"Dubar","year":"2013","journal-title":"Angew. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41570-017-0066","article-title":"The medicinal chemistry of ferrocene and its derivatives","volume":"1","author":"Patra","year":"2017","journal-title":"Nat. Rev. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"14906","DOI":"10.1039\/C5DT02378E","article-title":"Polyamine quinoline rhodium complexes: Synthesis and pharmacological evaluation as antiparasitic agents against Plasmodium falciparum and Trichomonas vaginalis","volume":"44","author":"Stringer","year":"2015","journal-title":"Dalton Trans."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0065-3055(08)60354-8","article-title":"Organometallic chemistry of arene ruthenium and osmium complexes","volume":"Volume 29","author":"Touchard","year":"1989","journal-title":"Advances in Organometallic Chemistry"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"14841","DOI":"10.1039\/C8DT03432J","article-title":"Future potential of osmium complexes as anticancer drug candidates, photosensitizers and organelle-targeted probes","volume":"47","author":"Zhang","year":"2018","journal-title":"Dalton Trans."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Kumaresan, D., Shankar, K., Vaidya, S., and Schmehl, R.H. (2007). Photochemistry and photophysics of coordination compounds: Osmium. Photochemistry and Photophysics of Coordination Compounds II, Springer.","DOI":"10.1007\/128_2007_140"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/php.12767","article-title":"Novel Osmium-based Coordination Complexes as Photosensitizers for Panchromatic Photodynamic Therapy","volume":"93","author":"Lazic","year":"2017","journal-title":"Photochem. Photobiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"12341","DOI":"10.1039\/C7CC07776A","article-title":"A NIR phosphorescent osmium (II) complex as a lysosome tracking reagent and photodynamic therapeutic agent","volume":"53","author":"Zhang","year":"2017","journal-title":"Chem. Commun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.drudis.2014.06.016","article-title":"Development of anticancer agents: Wizardry with osmium","volume":"19","author":"Hanif","year":"2014","journal-title":"Drug Discov. Today"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1039\/C7CS00332C","article-title":"Structure\u2013activity relationships for ruthenium and osmium anticancer agents\u2013towards clinical development","volume":"47","author":"Gerner","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"112483","DOI":"10.1016\/j.ejmech.2020.112483","article-title":"Synthesis, structure and anti-cancer activity of osmium complexes bearing \u03c0-bound arene substituents and phosphane Co-Ligands: A review","volume":"201","author":"Nabiyeva","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","article-title":"Platinum compounds: A new class of potent antitumour agents","volume":"222","author":"Rosenberg","year":"1969","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/acs.chemrev.5b00597","article-title":"The next generation of platinum drugs: Targeted Pt (II) agents, nanoparticle delivery, and Pt (IV) prodrugs","volume":"116","author":"Johnstone","year":"2016","journal-title":"Chem. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00280-016-2976-z","article-title":"Platinum-based drugs: Past, present and future","volume":"77","author":"Dilruba","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Baartzes, N., Stringer, T., and Smith, G.S. (2019). Targeting Sensitive-Strain and Resistant-Strain Malaria Parasites through a Metal-Based Approach. Advances in Bioorganometallic Chemistry, Elsevier.","DOI":"10.1016\/B978-0-12-814197-7.00010-8"},{"key":"ref_77","first-page":"52","article-title":"Transition metal-based anti-malarial","volume":"20112","author":"Sekhon","year":"2012","journal-title":"J. Pharm. Educ. Res."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Rai, M., Ingle, A.P., and Medici, S. (2018). Metal-Based Drugs for Treatment of Malaria. Biomedical Applications of Metals, Springer International Publishing.","DOI":"10.1007\/978-3-319-74814-6"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/1475-2875-13-471","article-title":"Metal-chloroquine derivatives as possible anti-malarial drugs: Evaluation of anti-malarial activity and mode of action","volume":"13","author":"Navarro","year":"2014","journal-title":"Malar. J."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1021\/om300334z","article-title":"Exploring the versatility of cycloplatinated thiosemicarbazones as antitumor and antiparasitic agents","volume":"31","author":"Chellan","year":"2012","journal-title":"Organometallics"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/B978-0-08-018876-8.50011-6","article-title":"7\u2014PLATINUM","volume":"Volume 25","author":"Livingstone","year":"1973","journal-title":"The Chemistry of Ruthenium, Rhodium, Palladium, Osmium, Iridium and Platinum"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/B978-0-08-018876-8.50010-4","article-title":"6\u2014PALLADIUM","volume":"Volume 25","author":"Livingstone","year":"1973","journal-title":"The Chemistry of Ruthenium, Rhodium, Palladium, Osmium, Iridium and Platinum"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1039\/C4CS00063C","article-title":"Anti-cancer palladium complexes: A focus on PdX 2 L 2, palladacycles and related complexes","volume":"43","author":"Kapdi","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejmech.2017.04.007","article-title":"Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives","volume":"142","author":"Rilak","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0022-1902(79)80496-0","article-title":"The synthesis and screening for anti-bacterial,-cancer,-fungicidal and-viral activities of some complexes of palladium and nickel","volume":"41","author":"Graham","year":"1979","journal-title":"J. Inorg. Nucl. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1002\/ejic.201000317","article-title":"Synthesis, structure and in vitro biological screening of palladium (II) complexes of functionalised salicylaldimine thiosemicarbazones as antimalarial and anticancer agents","volume":"2010","author":"Chellan","year":"2010","journal-title":"Eur. J. Inorg. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.jinorgbio.2011.09.021","article-title":"Platinum (II) and palladium (II) complexes with (N, N\u2032) and (C, N, N\u2032)\u2212 ligands derived from pyrazole as anticancer and antimalarial agents: Synthesis, characterization and in vitro activities","volume":"105","author":"Quirante","year":"2011","journal-title":"J. Inorg. Biochem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.jorganchem.2010.06.010","article-title":"Cyclopalladated complexes containing tridentate thiosemicarbazone ligands of biological significance: Synthesis, structure and antimalarial activity","volume":"695","author":"Chellan","year":"2010","journal-title":"J. Organomet. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jorganchem.2013.02.024","article-title":"Synthesis, characterization and antiplasmodial evaluation of cyclopalladated thiosemicarbazone complexes","volume":"736","author":"Adams","year":"2013","journal-title":"J. Organomet. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1039\/C5DT04918K","article-title":"Cyclopalladated organosilane\u2013tethered thiosemicarbazones: Novel strategies for improving antiplasmodial activity","volume":"45","author":"Adams","year":"2016","journal-title":"Dalton Trans."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00436-003-0830-9","article-title":"In vitro antimalarial activity of metalloporphyrins against Plasmodium falciparum","volume":"90","author":"Begum","year":"2003","journal-title":"Parasitol. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1177\/41.7.8515048","article-title":"A histochemical approach to the mechanism of action of cisplatin and its analogues","volume":"41","author":"Aggarwal","year":"1993","journal-title":"J. Histochem. Cytochem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: Molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00436-006-0313-x","article-title":"Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors","volume":"100","author":"Hempelmann","year":"2007","journal-title":"Parasitol. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7258(98)00012-6","article-title":"Quinoline antimalarials: Mechanisms of action and resistance and prospects for new agents","volume":"79","author":"Foley","year":"1998","journal-title":"Pharmacol. Ther."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1517\/13543776.11.2.185","article-title":"Quinoline antimalarials","volume":"11","author":"Egan","year":"2001","journal-title":"Opin. Ther. Pat."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.3390\/molecules13112900","article-title":"Ferroquine, an ingenious antimalarial drug\u2013thoughts on the mechanism of action","volume":"13","author":"Dubar","year":"2008","journal-title":"Molecules"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1021\/om300296n","article-title":"Bioorganometallic compounds with antimalarial targets: Inhibiting hemozoin formation","volume":"31","author":"Navarro","year":"2012","journal-title":"Organometallics"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1021\/cb100322v","article-title":"The antimalarial ferroquine: Role of the metal and intramolecular hydrogen bond in activity and resistance","volume":"6","author":"Dubar","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ab.2004.11.022","article-title":"A colorimetric high-throughput \u03b2-hematin inhibition screening assay for use in the search for antimalarial compounds","volume":"338","author":"Ncokazi","year":"2005","journal-title":"Anal. Biochem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0092-8674(03)01023-7","article-title":"Plasmodium biology: Genomic gleanings","volume":"115","author":"Aravind","year":"2003","journal-title":"Cell"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.molbiopara.2007.04.009","article-title":"Pharmacogenomic analyses of targeting the AT-rich malaria parasite genome with AT-specific alkylating drugs","volume":"154","author":"Woynarowski","year":"2007","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1021\/jm9018383","article-title":"Antimalarial versus cytotoxic properties of dual drugs derived from 4-aminoquinolines and Mannich bases: Interaction with DNA","volume":"53","author":"Wenzel","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/jm4014778","article-title":"Quinoline\u2013pyrimidine hybrids: Synthesis, antiplasmodial activity, SAR, and mode of action studies","volume":"57","author":"Singh","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1007\/s00044-012-0133-8","article-title":"Synthesis, DNA binding, hemolytic, and anti-cancer assays of curcumin I-based ligands and their ruthenium (III) complexes","volume":"22","author":"Ali","year":"2013","journal-title":"Med. Chem. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/157340613804488297","article-title":"Syntheses, DNA binding and anticancer profiles of L-glutamic acid ligand and its copper (II) and ruthenium (III) complexes","volume":"9","author":"Ali","year":"2013","journal-title":"Med. Chem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jphotobiol.2014.04.019","article-title":"Ruthenium (III) S-methylisothiosemicarbazone Schiff base complexes bearing PPh3\/AsPh3 coligand: Synthesis, structure and biological investigations, including antioxidant, DNA and protein interaction, and in vitro anticancer activities","volume":"138","author":"Prakash","year":"2014","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.saa.2014.01.050","article-title":"Spectral, electrochemical, thermal, DNA binding ability, antioxidant and antibacterial studies of novel Ru (III) Schiff base complexes","volume":"124","author":"Aziz","year":"2014","journal-title":"Spectrochim. Acta A"},{"key":"ref_109","first-page":"1","article-title":"Transfer hydrogenation catalysis in cells as a new approach to anticancer drug design","volume":"6","author":"Habtemariam","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"8792","DOI":"10.1021\/jacs.7b03872","article-title":"Intracellular transfer hydrogenation mediated by unprotected organoiridium catalysts","volume":"139","author":"Bose","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1021\/acs.chemrev.8b00493","article-title":"Intracellular catalysis with selected metal complexes and metallic nanoparticles: Advances toward the development of catalytic metallodrugs","volume":"119","year":"2019","journal-title":"Chem. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nchem.2918","article-title":"Asymmetric transfer hydrogenation by synthetic catalysts in cancer cells","volume":"10","author":"Coverdale","year":"2018","journal-title":"Nat. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1002\/ejic.201800284","article-title":"Ruthenium Arene Complexes with \u03b1-Aminoacidato Ligands: New Insights into Transfer Hydrogenation Reactions and Cytotoxic Behaviour","volume":"2018","author":"Biancalana","year":"2018","journal-title":"Eur. J. Inorg. Chem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1021\/acs.organomet.8b00132","article-title":"Transfer hydrogenation and antiproliferative activity of tethered half-sandwich organoruthenium catalysts","volume":"37","author":"Chen","year":"2018","journal-title":"Organometallics"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jinorgbio.2015.10.008","article-title":"Half-sandwich rhodium (III) transfer hydrogenation catalysts: Reduction of NAD+ and pyruvate, and antiproliferative activity","volume":"153","author":"Habtemariam","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"13143","DOI":"10.1039\/C9DT02030F","article-title":"N, O-Chelating quinoline-based half-sandwich organorhodium and-iridium complexes: Synthesis, antiplasmodial activity and preliminary evaluation as transfer hydrogenation catalysts for the reduction of NAD+","volume":"48","author":"Stringer","year":"2019","journal-title":"Dalton Trans."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4269\/ajtmh.1993.48.205","article-title":"Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia","volume":"48","author":"Makler","year":"1993","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/(SICI)1521-3773(19990517)38:10<1429::AID-ANIE1429>3.0.CO;2-Q","article-title":"Regioselective Reduction of NAD+ Models with [Cp* Rh (bpy) H]+: Structure\u2013Activity Relationships and Mechanistic Aspects in the Formation of the 1, 4-NADH Derivatives","volume":"38","author":"Lo","year":"1999","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1021\/ic010562z","article-title":"Bioorganometallic Chemistry. 13. Regioselective Reduction of NAD+ Models, 1-Benzylnicotinamde Triflate and \u03b2-Nicotinamide Ribose-5\u2032-methyl Phosphate, with in Situ Generated [Cp* Rh (Bpy) H]+: Structure\u2212 Activity Relationships, Kinetics, and Mechanistic Aspects in the Formation of the 1, 4-NADH Derivatives","volume":"40","author":"Lo","year":"2001","journal-title":"Inorg. Chem."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/22\/5276\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:32:29Z","timestamp":1760178749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/22\/5276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":119,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["molecules25225276"],"URL":"https:\/\/doi.org\/10.3390\/molecules25225276","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]}}}